Online Impact
Statistics from Altmetric.com
ARTICLE USAGE
Cited By
Article Information
Volume 11, Issue 3, pp. 1000-1009
PubMed
Published By
Print ISSN
Online ISSN
History
- Accepted October 20, 2004
- Received April 13, 2004
- Revision received October 19, 2004
- Published first February 11, 2005.
Copyright & Usage
American Association for Cancer Research
Author Information
- Hiroyuki Hariu1,
- Yoshihiko Hirohashi1,
- Toshihiko Torigoe1,
- Hiroko Asanuma1,
- Midori Hariu1,
- Yasuaki Tamura1,
- Katsuyuki Aketa1,2,
- Chika Nabeta1,
- Katsuya Nakanishi1,
- Kenjiro Kamiguchi1,
- Yoshinori Mano1,
- Hiroshi Kitamura1,3,
- Junichi Kobayashi1,
- Tomohide Tsukahara1,
- Noriharu Shijubo1,4 and
- Noriyuki Sato1
- Departments of 1Pathology, 2Internal Medicine, and 3Urology, Sapporo Medical University School of Medicine and 4Sapporo Hospital of Hokkaido Railway Company, Chuo-ku, Sapporo, Japan
- Requests for reprints:
Toshihiko Torigoe, Department of Pathology, Sapporo Medical University School of Medicine, South-1 West-17 Chuo-ku, Sapporo 060-8556, Japan. Phone: 81-11-613-8374; Fax: 81-11-643-2310; E-mail: torigoe{at}sapmed.ac.jp.
February 2005
Volume 11, Issue 3
Volume 11, Issue 3
Aberrant Expression and Potency as a Cancer Immunotherapy Target of Inhibitor of Apoptosis Protein Family, Livin/ML-IAP in Lung Cancer
Jump to section
Advertisement